Rhumbline Advisers cut its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 44.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 77,263 shares of the company's stock after selling 61,214 shares during the quarter. Rhumbline Advisers owned 0.16% of Nu Skin Enterprises worth $561,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of NUS. Bank of New York Mellon Corp raised its stake in shares of Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock worth $4,226,000 after purchasing an additional 95,938 shares during the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter worth approximately $115,000. US Bancorp DE increased its position in shares of Nu Skin Enterprises by 424.2% during the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock valued at $51,000 after acquiring an additional 6,037 shares during the last quarter. SBI Securities Co. Ltd. purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $157,000. Finally, Victory Capital Management Inc. purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $141,000. 82.84% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, insider Steven Keith Hatchett bought 6,500 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was acquired at an average cost of $7.54 per share, with a total value of $49,010.00. Following the completion of the transaction, the insider now directly owns 162,065 shares of the company's stock, valued at $1,221,970.10. This represents a 4.18% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Edwina D. Woodbury sold 4,532 shares of the firm's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $8.44, for a total value of $38,250.08. Following the completion of the transaction, the director now directly owns 42,947 shares of the company's stock, valued at $362,472.68. The trade was a 9.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.
Nu Skin Enterprises Stock Performance
Shares of NUS traded up $0.23 on Thursday, reaching $7.96. 521,163 shares of the company's stock traded hands, compared to its average volume of 799,769. The company has a current ratio of 2.02, a quick ratio of 1.29 and a debt-to-equity ratio of 0.29. The stock has a market cap of $393.30 million, a PE ratio of -9.95 and a beta of 0.98. The stock's 50 day simple moving average is $7.11 and its two-hundred day simple moving average is $7.10. Nu Skin Enterprises, Inc. has a 52-week low of $5.32 and a 52-week high of $11.64.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.23 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The company had revenue of $364.49 million during the quarter, compared to the consensus estimate of $352.06 million. Nu Skin Enterprises had a positive return on equity of 6.99% and a negative net margin of 2.30%. On average, analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th were given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 3.02%. The ex-dividend date was Friday, May 30th. Nu Skin Enterprises's dividend payout ratio is currently -30.00%.
Analyst Ratings Changes
Separately, Wall Street Zen raised Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.
Read Our Latest Report on NUS
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.